DiaMedica Therapeutics Inc. Common Stock
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMAC and other ETFs, options, and stocks.About DMAC
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD).
DMAC Key Statistics
Stock Snapshot
As of today, DiaMedica Therapeutics Inc. Common Stock(DMAC) shares are valued at $8.59. The company's market cap stands at 448.49M, with a P/E ratio of -11.81.
During the trading session on 2025-12-25, DiaMedica Therapeutics Inc. Common Stock(DMAC) shares reached a daily high of $8.59 and a low of $8.30. At a current price of $8.59, the stock is +3.6% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 89.15K, compared to an average daily volume of 529.45K.
Over the past 52 weeks, DiaMedica Therapeutics Inc. Common Stock(DMAC) stock has traded between a high of $10.42 and a low of $3.19.
Over the past 52 weeks, DiaMedica Therapeutics Inc. Common Stock(DMAC) stock has traded between a high of $10.42 and a low of $3.19.